GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NGL Fine-Chem Ltd (BOM:524774) » Definitions » PB Ratio

NGL Fine-Chem (BOM:524774) PB Ratio : 4.15 (As of Dec. 12, 2024)


View and export this data going back to 1995. Start your Free Trial

What is NGL Fine-Chem PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-12), NGL Fine-Chem's share price is ₹1884.70. NGL Fine-Chem's Book Value per Share for the quarter that ended in Sep. 2024 was ₹453.70. Hence, NGL Fine-Chem's PB Ratio of today is 4.15.

Good Sign:

NGL Fine-Chem Ltd stock PB Ratio (=4.09) is close to 1-year low of 3.95

The historical rank and industry rank for NGL Fine-Chem's PB Ratio or its related term are showing as below:

BOM:524774' s PB Ratio Range Over the Past 10 Years
Min: 1.37   Med: 4.04   Max: 10.87
Current: 4.16

During the past 13 years, NGL Fine-Chem's highest PB Ratio was 10.87. The lowest was 1.37. And the median was 4.04.

BOM:524774's PB Ratio is ranked worse than
77.47% of 941 companies
in the Drug Manufacturers industry
Industry Median: 2.09 vs BOM:524774: 4.16

During the past 12 months, NGL Fine-Chem's average Book Value Per Share Growth Rate was 16.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 19.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 25.50% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 27.00% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of NGL Fine-Chem was 34.30% per year. The lowest was 13.60% per year. And the median was 27.40% per year.

Back to Basics: PB Ratio


NGL Fine-Chem PB Ratio Historical Data

The historical data trend for NGL Fine-Chem's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NGL Fine-Chem PB Ratio Chart

NGL Fine-Chem Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.58 6.13 5.95 3.32 4.92

NGL Fine-Chem Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.01 - 4.92 - 4.44

Competitive Comparison of NGL Fine-Chem's PB Ratio

For the Drug Manufacturers - General subindustry, NGL Fine-Chem's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NGL Fine-Chem's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NGL Fine-Chem's PB Ratio distribution charts can be found below:

* The bar in red indicates where NGL Fine-Chem's PB Ratio falls into.



NGL Fine-Chem PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

NGL Fine-Chem's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=1884.70/453.697
=4.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


NGL Fine-Chem  (BOM:524774) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


NGL Fine-Chem PB Ratio Related Terms

Thank you for viewing the detailed overview of NGL Fine-Chem's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


NGL Fine-Chem Business Description

Traded in Other Exchanges
Address
301, E Square, Subhash Road, Vile Parle (East), Mumbai, MH, IND, 400057
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. The company is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. Its product includes Active Pharmaceutical Ingredients (APIs) animal health, APIs human health, Intermediates and Finished dosage form, of which maximum revenue is generated from Veterinary APIs. Its geographical segments include India, Europe, Asia Pacific, United States, and Rest of the world. The Group's business activities fall within a single business segment of pharmaceuticals.

NGL Fine-Chem Headlines

No Headlines